Evaluated by American Medical Association Council on Drugs. Price, $4. Pp 902. J. B. Lippincott Company, E. Washington Sq, Philadelphia 5, 1963.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Here is a book in search of an audience, a well-printed and well-bound volume that has not assumed its rightful place as an aid in medical practice. The monographs about groups of drugs, and about specific drugs for diagnosis and treatment, are well done and impartial. The older ones tend to run on and on but the newer are compact and more forceful.
Unfortunately, the book's target was never determined. It is not minute enough for the pharmacologist but too long for the busy physician. There is no cross-indexing; a drug which may have several actions cannot be found in a therapeutic index. There is no preference or priority as to the importance of the material so that the busy physician can see at a glance that the drug is too dangerous or too ineffective for a particular patient's needs. Basically, the physician confronted with a choice wants to know
Gorrell RL. New and Nonofficial Drugs 1963.. Arch Intern Med. 1963;112(4):624. doi:10.1001/archinte.1963.03860040220029